Molecular targeted therapies for breast cancer treatment.
about
Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts.A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.Estrogen suppresses MLK3-mediated apoptosis sensitivity in ER+ breast cancer cells.A quantitative systems approach to identify paracrine mechanisms that locally suppress immune response to Interleukin-12 in the B16 melanoma model.Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer.Modulation of expression of heat shock proteins and apoptosis by Flueggea leucopyrus (Willd) decoction in three breast cancer phenotypes.Distinct regulation of cytoplasmic calcium signals and cell death pathways by different plasma membrane calcium ATPase isoforms in MDA-MB-231 breast cancer cells.Differential proteomic analysis of pathway biomarkers in human breast cancer by integrated bioinformatics.Identifying grade/stage-related active modules in human co-regulatory networks: a case study for breast cancerEavesdropping on altered cell-to-cell signaling in cancer by secretome profilingPhosphatidylinositol glycan anchor biosynthesis, class X containing complex promotes cancer cell proliferation through suppression of EHD2 and ZIC1, putative tumor suppressors.The tumor proteasome as a novel target for gold(III) complexes: implications for breast cancer therapyLipid-based nanocarriers for breast cancer treatment - comprehensive review.The enigmatic role of RUNX1 in female-related cancers - current knowledge & future perspectives.Inhibition of metadherin sensitizes breast cancer cells to AZD6244.Smac-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis.An optimal transportation approach for nuclear structure-based pathology.The ANK repeats of Notch-4/Int3 activate NF-κB canonical pathway in the absence of Rbpj and causes mammary tumorigenesis.A comparative study of Ki-67 antigen expression between luminal A and triple-negative subtypes of breast cancer.Effects of exercise on angiogenesis and apoptosis-related molecules, quality of life, fatigue and depression in breast cancer patients.The Impact of Exercise Training on Breast Cancer.
P2860
Q33742688-4A87D0F3-BB99-4747-9F4A-F84FBB2A96C5Q33878984-1FB9BE7A-5AB1-4E99-A9CF-930CAAC6AAB9Q34236080-11438F4A-C77B-4CDF-B470-9A71590778C4Q34331673-DE3DCB28-8848-4E09-B4E4-6CB903F9F34BQ34420914-2AC0F963-3178-4F1C-B96F-5E58ED5A7A04Q35836614-FBF8BEAA-B0D6-4719-891A-FC1E29F0BE76Q36217154-2971A20D-AE46-406D-9E4B-5A2562691EFFQ36403283-75DC3F04-3438-4768-953C-CDFEC3920D5DQ36463610-B43805A9-1BFD-4613-A802-7B644FCD9450Q36836135-08634BEC-C482-459A-91C6-E2E862804132Q37103985-C7982322-CD84-4267-8EA4-FCE260142DF4Q37175850-78267097-A63F-4B68-9EB6-9A806332D6F6Q38597794-CE8419DE-2668-4CD5-B7BC-AE4C8EFD8446Q38743681-A110CA8C-491E-4BF1-81B6-8172207837DDQ39396267-009A114D-22BD-4BF6-9CE8-2CD1D369A304Q39477486-3BF7308C-170B-4561-AE67-F574294028B5Q42274144-3F8C7F8A-2A3B-4060-B1A6-53BE0858A72BQ42652857-F20F5F74-5795-4DE4-BF09-B734F0B07F24Q47986847-DB6690D7-67F4-48AA-934E-9A21CA1E9134Q48232163-B5D58161-AA6F-4CEC-A5F3-8D1110712614Q51738454-8B2C456B-9775-4464-822D-2C642F7E9F56
P2860
Molecular targeted therapies for breast cancer treatment.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Molecular targeted therapies for breast cancer treatment.
@en
type
label
Molecular targeted therapies for breast cancer treatment.
@en
prefLabel
Molecular targeted therapies for breast cancer treatment.
@en
P2093
P2860
P356
P1476
Molecular targeted therapies for breast cancer treatment.
@en
P2093
Burkhard Brandt
Claus M Schlotter
Heike Allgayer
P2860
P2888
P356
10.1186/BCR2112
P577
2008-07-24T00:00:00Z
P5875
P6179
1020385656